With as low as milligram quantities of API, we can provide physical, chemical and biological characterization data to drive quick and sound decisions on the best formulation approach for late discovery and preclinical phases through the development of human clinical trial material.
Our analytical development team is well-versed to facilitate the development of the analytical methods and testing of prototype formulations, raw materials, and drug products spanning from Pre-IND early phase to late registration.
A full list of all our available Animal Models includes: Bladder cancer, Blood cancer, Brain cancer, Breast cancer, Cervix cancer, Choriocarcinoma, Colorectal cancer, Esophageal cancer, Fibrosarcoma, Gastric cancer, Kidney cancer, and more…
Partner with our experienced and specialized team to solve complex chemistry problems. As a service-oriented business, we offer long-term partnerships and tailored solutions. We will help you to achieve your chemistry goals.
Discover our integrated drug discovery solutions with a wide range of cancer research models, immuno-oncology techniques, and comprehensive cellular and biomarker analyses. Our services include drug target discovery, potency and efficacy evaluation, and access to the LOCUS Queryable Database to identify oncology models.
Partner with us for your drug discovery project needs. We provide a wide range of services, including custom assays, stable cell line generation, SPR and BLI services, and fragment library screening, with broad expertise in therapeutic disease areas and target class.
Our comprehensive range of services, from early drug discovery to commercial API production, includes drug substance development, process R&D, scale-up synthesis, and integrated IND enabling services. Our expert team is dedicated to ensuring quality and efficiency to help you bring new drugs to market quickly and effectively.
We provide our biotech and pharmaceutical partners with fully integrated services to support their efforts from target identification through to commercial drug product manufacturing. Download this flyer to see the breadth of our services.
Offering a diverse and efficient fragment library with novel scaffolds and important pharmacophores, excluding functional groups with known structural alerts, for drug discovery projects. Learn more about our screening and hit follow-up options.
A case study on: Formulation Development of Amorphous Solid Dispersions by Combined In-Silico Modelling, High-Throughput Screening and in-vivo PK Study
With focused centers of excellence in the United States and China, BioDuro-Sundia has the flexibility and breadth to engage with you at any level of the drug development and manufacturing process.
BioDuro-Sundia is able to undertake preclinical studies related to radionuclide markers including 35S, 32P, 33P, 125I, 14C, 3H, providing an integrated platform for compound screening and MOA verification